Crotylbarbital

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by CheMoBot (talk | contribs) at 10:38, 11 November 2014 (Updating {{drugbox}} (no changed fields - added verified revid - updated 'CAS_number_Ref', 'verifiedrevid') per Chem/Drugbox validation (report errors or bugs)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Crotylbarbital
Clinical data
ATC code
  • none
Identifiers
  • 5-but-2-enyl-5-ethyl-1,3-diazinane-2,4,6-trione
CAS Number
PubChem CID
ChemSpider
CompTox Dashboard (EPA)
ECHA InfoCard100.016.162 Edit this at Wikidata
Chemical and physical data
FormulaC10H14N2O3
Molar mass210.23 g/mol g·mol−1
3D model (JSmol)
  • O=C1NC(=O)NC(=O)C1(CC)C/C=C/C
  • InChI=1S/C10H14N2O3/c1-3-5-6-10(4-2)7(13)11-9(15)12-8(10)14/h3,5H,4,6H2,1-2H3,(H2,11,12,13,14,15)/b5-3+ checkY
  • Key:KNMOHCLEINXVBG-HWKANZROSA-N checkY
  (verify)

Crotylbarbital (Mepertan, Kalipnon, Barotal), also known as crotarbital, is a barbiturate derivative developed by Eli Lilly in the 1930s[1]m It has sedative and hypnotic effects,[2] and was used for the treatment of insomnia until it was replaced by newer alternative drugs with less side effects and lower risk of overdose.

See also

References

  1. ^ US Patent 2250422
  2. ^ Walther T, Meyer FP, Puchta K, Walther H. Effect of an acute dose of crotylbarbital on reaction time and attention testing in healthy human subjects. International Journal of Clinical Pharmacology, Therapy and Toxicology. 1983 Jun;21(6):306-10.